aoncology.com - רווח תפעולי EBITDA AONC

American Oncology Network generates revenue by providing IT infrastructure and administrative support to private oncology centers in the US. The EBITDA level reflects cash flow dynamics, where the value of describes the current yield. Stability is driven by inelastic demand and favorable bulk drug procurement, while niche regional concentration risks are mitigated through the implementation of centralized pharmacy services.

This indicator captures the actual cash flow from operating activities before depreciation, allowing for an assessment of cash generation efficiency net of operating expenses. The implementation of AI analytics and document workflow automation at American Oncology Network (AONC) reduces administrative costs, which is reflected in the positive trend of gross operating profit before depreciation and confirms the high capital resilience of the issuer.